United Therapeutics Corporation Announces Appointment of Victor Dzau to its Board of DirectorsBusiness Wire • 07/23/26
United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Q2 ReleaseZacks Investment Research • 07/22/26
United Therapeutics Corporation to Report Second Quarter 2026 Financial Results Before Market Open on Wednesday, August 5, 2026Business Wire • 07/22/26
United Therapeutics Stock Rises 14% YTD: Here's What You Need to KnowZacks Investment Research • 07/09/26
United Therapeutics: Trifecta Of 2026 Tyvaso Franchise Filings Makes It A Compelling BuySeeking Alpha • 07/06/26
UTHR Strengthens Regenerative Medicine Platform With Thymmune DealZacks Investment Research • 07/03/26
United Therapeutics Corporation Announces FDA Approval of the LungFX™ Device for Centralized Ex Vivo Lung PerfusionBusiness Wire • 06/29/26
The space race is coming for pharma: Why drug development is heading to lower Earth orbitCNBC • 06/09/26
Why Is United Therapeutics (UTHR) Down 3.8% Since Last Earnings Report?Zacks Investment Research • 06/05/26
United Therapeutics Corporation (UTHR) Presents at Jefferies Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/03/26
United Therapeutics Corporation to Present at the Jefferies Global Healthcare ConferenceBusiness Wire • 05/27/26
United Therapeutics Corporation (UTHR) Presents at RBC Capital Markets Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/19/26
United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026Business Wire • 05/18/26
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026Business Wire • 05/17/26
United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical TrialBusiness Wire • 05/15/26
United Therapeutics Corporation to Present at the RBC Capital Markets Global Healthcare ConferenceBusiness Wire • 05/12/26
United Therapeutics Corporation Presents New Data from TETON-1, ADVANCE OUTCOMES, and Additional Research in Pulmonary Hypertension and Pulmonary Fibrosis at ATS 2026Business Wire • 05/11/26